Clinical trial
Comparative Study of Palonosetron With Granisetron as a Control in Patients…
NCT00359567 · Taiho Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00359567 |
|---|---|
| Title | Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy |
| Official title | Comparative Study of Intravenous Single Doses of Palonosetron (PALO) With Granisetron Hydrochloride as a Control in Patients Receiving Highly Emetogenic Chemotherapy |
| Lead sponsor | Taiho Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chemotherapy-Induced Nausea and Vomiting |
| Intervention type | Drug |
| Interventions | palonosetron, granisetron hydrochloride |
| Enrollment | 1,140 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Aug 2, 2006 |
| Last update posted | Jul 7, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: